Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 3

Review

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

          
Total article views   Abstract views HTML views PDF downloads Totals
9,033 Dovepress* 8,115 386+ 4,016 8,501
PubMed Central* 0 532 64 532
Totals 8,115 918 4,080 9,033
*Since 4 August 2011
+Since July 2016

View citations on PubMed Central and Google Scholar